openPR Logo
Press release

Peripheral IV Catheter Market is Expected to Progress at a CAGR of 5.8% to Reach US$ 1,865.4 Million by 2034 | Fact.MR Report

05-02-2024 10:00 AM CET | Health & Medicine

Press release from: Fact.MR

Peripheral IV Catheter Market

Peripheral IV Catheter Market

The peripheral IV catheter market in US is predicted to account for 88.6% of the North American market in 2024. It is projected that the US market for peripheral IV catheters would grow by US$ 685 million by 2024. By 2034, the market is expected to reach US$ 1,029 million with a 4.2% compound annual growth rate.

It is projected that the size of the peripheral IV catheter market worldwide would reach US$ 1,058.6 million by 2024. By 2034, the market is expected to grow at a 5.8% CAGR and reach US$ 1,865.4 million.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐š ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.factmr.com/connectus/sample?flag=S&rep_id=9654

For public relations (PR) specialists, the peripheral I.V. catheter market offers a distinctive environment with a wealth of chances for strategic communication and brand development. We will examine the dynamics, difficulties, and future growth potential of the Peripheral IV Catheter market in this study, highlighting the critical role public relations plays in influencing attitudes, building connections, and propelling commercial success. The global peripheral I.V. catheter market is expected to rise steadily over the next several years due to a mix of ongoing technology advancements, greater environmental consciousness, and an increasing demand for more efficient operations. It is expected that industry participants would focus on product innovation, strategic partnerships, and global expansion in order to take advantage of the changing market prospects.

๐“๐จ๐ฉ ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐๐ซ๐จ๐ฉ๐ž๐ฅ๐ฅ๐ข๐ง๐  ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ข๐ง ๐ญ๐ก๐ž ๐๐ž๐ซ๐ข๐ฉ๐ก๐ž๐ซ๐š๐ฅ ๐ˆ๐• ๐‚๐š๐ญ๐ก๐ž๐ญ๐ž๐ซ ๐Œ๐š๐ซ๐ค๐ž๐ญ

Peripheral IV catheter sales are benefiting from an aging population and an increase in the prevalence of chronic illnesses.
The market is being driven by a rise in the number of hospitalizations and a notable use of safety-ported short peripheral intravenous catheters.
Peripheral IV catheter use is predicted to be significantly accelerated by the desire to reduce needle-stick injuries and growing healthcare costs.
Peripheral IV catheter use is rising as more people become aware of the benefits of early diagnosis in obtaining blood samples for testing.
Peripheral intravenous catheter use is rising as a result of the rise in chronic illnesses like diabetes, neurological diseases, infectious disorders, etc. that are creating opportunities for players to conduct disease treatment awareness campaigns.
The market is expected to grow as a result of investments made in the development and production of effective peripheral IV catheters, given the growing patient population.

๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐‹๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž

Key players in the peripheral IV catheter market include Becton, Dickinson, and Company, B. Braun Melsungen AG, Smiths Group plc., Terumo Corporation, Venner Medical, Vygon, Teleflex Incorporated, C. R. Bard, Inc., NIPRO Medical Corporation, and Argon Medical Devices, Inc.

There are both domestic and foreign competitors in this fiercely competitive market. Small and medium-sized businesses are focusing on increasing their market share by investing in technology innovations. Players also use other inorganic and organic tactics, like as alliances, mergers, acquisitions, and the introduction of new products.

Recent Developments in the Peripheral IV Catheter Market

In September 2022, B. Braun Medical Inc. purchased numerous items from Starboard Medical. These devices are used to fasten the Clik-FIX peripheral catheter.

In March 2022, Shockwave Medical Inc. announced that the Shockwave M5+ peripheral IVL catheter-which received FDA certification and the CE Mark-will be made commercially accessible globally.

In July 2022, B. Braun Medical Inc. introduced the Introcan Safety 2 IV Catheter, which allows for single-time blood control. The most recent invention from B. Braun lowers the risk of needlestick injuries and blood exposure while also improving the safety quotient of IV for medical professionals.

๐†๐ž๐ญ ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐Ÿ๐จ๐ซ ๐’๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐’๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ: https://www.factmr.com/connectus/sample?flag=RC&rep_id=9654

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐จ๐Ÿ ๐๐ž๐ซ๐ข๐ฉ๐ก๐ž๐ซ๐š๐ฅ ๐ˆ๐• ๐‚๐š๐ญ๐ก๐ž๐ญ๐ž๐ซ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก

By Product Type:
Power Injected PICC
Conventional PICC

By Design Type:
Single Lumen
Double Lumen
Multiple Lumen

By End User:
Hospitals
Ambulatory Surgical Centers
Catheterization Labs

By Region:
North America
Europe
Latin America
East Asia
South Asia and Oceania
Middle East and Africa

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

๐€๐›๐จ๐ฎ๐ญ ๐…๐š๐œ๐ญ.๐Œ๐‘

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peripheral IV Catheter Market is Expected to Progress at a CAGR of 5.8% to Reach US$ 1,865.4 Million by 2034 | Fact.MR Report here

News-ID: 3482260 • Views: โ€ฆ

More Releases from Fact.MR

USA Demand for Microbiome Skincare Products in USA Outlook 2025-2035: Key Developments and Future Scope
USA Demand for Microbiome Skincare Products in USA Outlook 2025-2035: Key Develo โ€ฆ
The U.S. microbiome skincare market is projected to experience rapid, data-driven growth over the next decade, driven by rising consumer awareness, ingredient innovation, and the integration of personalized diagnostics. Analysts estimate the U.S. microbiome skincare segment at approximately USD 0.13 billion in 2025, with a projected increase to USD 0.35 billion by 2035, representing a compound annual growth rate (CAGR) of 10.4%. To access the complete data tables and in-depth insights,โ€ฆ
USA Demand for Lubricants in USA Outlook 2025-2035: Key Developments and Future Scope
USA Demand for Lubricants in USA Outlook 2025-2035: Key Developments and Future โ€ฆ
The U.S. lubricants market is projected to experience steady growth through 2035, driven by shifts in mobility, industrial demand, and sustainability trends. The market was valued at approximately $41.2 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 2.5%, reaching $52 billion by 2035. To access the complete data tables and in-depth insights, request a Discount On The Report here: https://www.factmr.com/connectus/sample?flag=S&rep_id=12463 โ€ฆ
European Demand for Intermodal Freight Transportation in UK Outlook 2025-2035: Key Developments and Future Scope
European Demand for Intermodal Freight Transportation in UK Outlook 2025-2035: K โ€ฆ
"Demand for intermodal freight transport connecting the UK and continental Europe is projected to grow at a CAGR of 6.8% between 2025 and 2035, driven by rising trade volumes, decarbonization mandates, and digital logistics innovations. The intermodal market, encompassing rail, short-sea shipping, and last-mile road delivery, is expected to handle over 18 million TEUs (twenty-foot equivalent units) annually by 2035, up from 10.2 million TEUs in 2025. To access the completeโ€ฆ
USA Demand for Hydroxyapatite in USA Outlook 2025-2035: Key Developments and Future Scope
USA Demand for Hydroxyapatite in USA Outlook 2025-2035: Key Developments and Fut โ€ฆ
The United States hydroxyapatite (HAp) market is projected to experience sustained, data-driven growth from 2025 through 2035, fueled by rising clinical demand, technological innovation, and expanded applications in regenerative medicine. Market modeling indicates that U.S. consumption of hydroxyapatite will nearly double over the next decade, with strong adoption in orthopedic, dental, and advanced biomaterial sectors. To access the complete data tables and in-depth insights, request a Discount On The Report here:โ€ฆ

All 5 Releases


More Releases for Peripheral

Key Trends Reshaping the Peripheral Arterial Disease Market: Innovative Shockwav โ€ฆ
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Peripheral Arterial Disease Market Size Growth Forecast: What to Expect by 2025? The overall valuation of the peripheral arterial disease sector has seen substantial expansion lately, projected to climb from $4.36 billion recorded in 2024 to reach $4.74 billion by 2025, reflecting an 8.7% compound annual growth rate overโ€ฆ
Peripheral Stent Market - Pioneering Solutions for Peripheral Artery Disease: Re โ€ฆ
Newark, New Castle, USA - Growth Plus Reports has published a new report on Peripheral Stent Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Peripheral Stent provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitiveโ€ฆ
Peripheral Vascular Devices Market - Empowering Mobility, Preserving Health: Ele โ€ฆ
Newark, New Castle, USA - new report, titled Peripheral Vascular Devices Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Peripheral Vascular Devices market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Peripheral Vascular Devices market. The report offers an overview ofโ€ฆ
Peripheral Vascular Devices Market Report 2018: Segmentation by Types (Periphera โ€ฆ
Global Peripheral Vascular Devices market research report provides company profile for Abbott Vascular, Bayer Healthcare, Volcano Corporation, Teleflex Medical and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentationโ€ฆ
Peripheral Vascular Device Market Size, Peripheral Vascular Device Market Share, โ€ฆ
Global Peripheral Vascular Device Market Size is observed to gain traction owing to the factors such as increasing research and development for developing several new product, and rising funding by the private organizations. Request for Sample of This Research Report @ https://bit.ly/2xjOKpC Top Key Player:- Abbott Laboratories Braun Melsungen AG Boston Scientific Corporation R. Brad, Inc. Cardinal Health, Inc. Medtronic plc. Cook Medical, Inc. Teruma Corporation Jude Medical, Inc. The Spectranetics Corporation Volcano Corporation Peripheral vascular disorder (PVD) is a blood circulation disorderโ€ฆ
Peripheral Artery Disease Market By Type (Peripheral Angioplasty Balloons, Perip โ€ฆ
Peripheral artery disease is characterized by plaque built up in the arteries carrying blood from heart to legs, arms, and other limbs. Peripheral artery disease in turn also increases the risk of other cardiovascular disorders such as heart attack, coronary heart disease, stroke, and ischemic attack. Request Sample At: https://www.bigmarketresearch.com/request-sample/1633533 The global peripheral artery disease market generated $3,136 million in 2016, and is projected to reach $4,980 million by 2023, registering aโ€ฆ